Back to the main directory
Press Release
- SANUWAVE Health Appoints Industry Veteran Andrew Walko as President by GlobeNewsWire
- BridgeBio Pharma Announces Opportunity for Accelerated Approval Pathway in Limb-girdle Muscular Dystrophy Type 2I (LGMD2I/R9) Based on Glycosylated Alpha-dystroglycan (⍺DG) Levels and Announces First Patient Dosed in FORTIFY Phase 3 Study by GlobeNewsWire
- Warrant Exercise and / or Redemption Instructions by GlobeNewsWire
- Anoto Group AB genomför en riktad emission av konvertibler och teckningsoptioner och tillförs 15,6 miljoner kronor by GlobeNewsWire
- Ferrari N.v.: Periodic Report on the Buyback Program by GlobeNewsWire
- Novo Nordisk A/S - share repurchase programme by GlobeNewsWire
- Appendix 4C – Q4 FY23 Quarterly Cash Flow Report by GlobeNewsWire
- onsemi Second Quarter 2023 Results Exceed Expectations by BusinessWire
- Customers Bancorp, Inc. Declares Quarterly Cash Dividend on Its Series E and Series F Preferred Stock by BusinessWire
- BioNTech Completes Acquisition of InstaDeep by GlobeNewsWire
- AMSC to Report First Quarter Fiscal Year 2023 Financial Results on August 9, 2023 by GlobeNewsWire
- Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending October, November, and December 2023 by GlobeNewsWire
- Ultragenyx Announces Initiation of Dosing in Second Cohort of Pivotal Phase 1/2/3 Cyprus2+ Trial Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease by GlobeNewsWire
- Duos Technologies Group Sets Second Quarter 2023 Earnings Call for Monday, August 14, 2023 at 4:30 PM ET by GlobeNewsWire
- Powerfleet Sets Second Quarter 2023 Conference Call for Tuesday, August 8, 2023 at 8:30 a.m. ET by GlobeNewsWire
- WDR Shareholders Overwhelmingly Approve Acquisition by FSX by GlobeNewsWire
- Reviva Pharmaceuticals to Present at Upcoming Investor Conferences in August by GlobeNewsWire
- Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly by GlobeNewsWire
- Nauticus Robotics Sets Second Quarter 2023 Earnings Conference Call for Friday, August 11 at 10:00 a.m. Eastern Time by GlobeNewsWire
- Daré Bioscience Announces Grant Award Supporting Development of Potential New Therapeutic Intervention for the Prevention of Idiopathic Preterm Birth by GlobeNewsWire
- Immutep Quarterly Activities Report Q4 FY23 by GlobeNewsWire
- Inspire Medical Systems, Inc. Announces the Addition of Charisse Y. Sparks, M.D. as Chief Medical Officer by GlobeNewsWire
- Recce Pharmaceuticals to Present at the 2023 Military Health System Research Symposium (MHSRS) by GlobeNewsWire
- OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET by GlobeNewsWire
- Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023 by GlobeNewsWire